Lim Kah Leong

Last updated
Lim Kah Leong
Lim Kah Leong.jpg
Prof Lim Kah Leong at Duke-NUS
Born
Lim Kah Leong

Nationality Singaporean
Alma mater Johns Hopkins University, Harvard University, IMCB
Occupation(s)Academic, Scientist
Website www.lkcmedicine.ntu.edu.sg/aboutus/Faculty-and-Staff/Pages/Lim-Kah-Leong.aspx

Lim Kah Leong, is a Singaporean neuroscientist and tenured full Professor and Vice Dean (Research) at the Lee Kong Chian School of Medicine, Nanyang Technological University (Singapore), where he is also a President's Chair Professor in Translational Neuroscience. He is concurrently the Research Director for Biomedical and Life Sciences at NTU. He was previously Chair of the Department of Physiology at the National University of Singapore, Singapore and the deputy director for research at the National Neuroscience Institute, Singapore. Dr. Lim is known for his research in Parkinson's Disease. [1] [2] His research focuses on unraveling the molecular mechanisms underlying neurodegenerative diseases, with the view to develop novel therapies aimed at effectively treating the disease.

Contents

Academic background

Dr Lim obtained his PhD from the Institute of Molecular and Cellular Biology, Singapore under Dr. Catherine Pallen and performed his postdoctoral studies at the department of Neurology, Johns Hopkins School of Medicine with Ted M. Dawson and the department of pathology, Harvard Medical School. [3] He returned in to Singapore in 2002 to lead a laboratory at the National Neuroscience Institute, Singapore.

Research

His research has focused on identifying the molecular events underlying Parkinson's disease (PD). He co-led the creation of the first two-photon, small molecule fluorogenic probe that can serve as a useful tool for the rapid assessment of an individual's potential risk for Parkinson's disease. [4] He has also pioneered the use of umbilical cord lining stem cells to create new dopamine producing neurons in mice. [5] He has also studied the relationship between Parkinson's Disease and cancer and has uncovered the role of a tumor suppressor known as parkin in brain cancer. [6]

Awards and recognition

Prof. Lim Kah Leong has been awarded the Outstanding Mentor Award from the Science Mentorship Program, Ministry of Education, Singapore in 2008. [7] He was also awarded the Khoo Discovery Award by the Khoo Teck Puat Foundation, Duke-NUS, Singapore the same year. His team was awarded the NMRC Translational and Clinical Research Flagship Programme Grant of S$25 million for their work on the degenerative neurological disease Parkinson's in 2014. [8] In 2018, he was awarded Singapore's highest accolade in science, the President's Science Award. [9] [10]

Related Research Articles

<span class="mw-page-title-main">McKnight Brain Institute</span>

The Evelyn F. and William L. McKnight Brain Institute (MBI) at the University of Florida (UF) is a comprehensive and diverse neuroscience research center that houses the UF College of Medicine’s four “neuro” departments: neuroscience, neurology, neurosurgery and psychiatry.

Nervous system diseases, also known as nervous system or neurological disorders, refers to a small class of medical conditions affecting the nervous system. This category encompasses over 600 different conditions, including genetic disorders, infections, cancer, seizure disorders, conditions with a cardiovascular origin, congenital and developmental disorders, and degenerative disorders.

Allied Academies is a reportedly fraudulent corporation chartered under the laws of North Carolina. Its postal address is in London, United Kingdom. It presents itself as an association of scholars, with supporting and encouraging research and the sharing and exchange of knowledge as its stated aims. The organization consists of 30 affiliate academies, which provide awards to academics and publish academic journals both online and in hard copy for members. Since 2015 the organization has been listed on Jeffrey Beall's list of "potential, possible, or probable predatory scholarly open-access publishers". It is in a partnership with OMICS Publishing Group which uses its website and logo. In 2018, OMICS owner Srinubabu Gedela declared that he had informed the Nevada court that Allied Academies was a subsidiary of OMICS International. During a conference in 2018, they falsely listed a prominent chemist among its organizing committee who had not agreed to this and was not affiliated with Allied Academies.

Avindra "Avi" Nath, is a physician-scientist who specializes in neuroimmunology. Nath is a senior investigator, and intramural clinical director of the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (NIH) in the United States. At NINDS, Nath also leads the Section of Infections of the Nervous System and plans to institute a translational research center. He previously served in several research and administrative positions at the Johns Hopkins Hospital and the Johns Hopkins University School of Medicine.

<span class="mw-page-title-main">Huda Zoghbi</span> Lebanese scientist

Huda Yahya Zoghbi, born Huda El-Hibri, is a Lebanese-born American geneticist, and a professor at the Departments of Molecular and Human Genetics, Neuroscience and Neurology at the Baylor College of Medicine. She is the director of the Jan and Dan Duncan Neurological Research Institute. She became the editor of the Annual Review of Neuroscience as of 2018.

<span class="mw-page-title-main">Duke–NUS Medical School</span>

The Duke–NUS Medical School (Duke–NUS) is a graduate medical school in Singapore. The school was set up in April 2005 as the Duke–NUS Graduate Medical School, Singapore's second medical school, after the Yong Loo Lin School of Medicine, and before the Lee Kong Chian School of Medicine. It is a collaboration between Duke University in the United States and the National University of Singapore in Singapore. Duke–NUS follows the American model of post-baccalaureate medical education, in which students begin their medical studies after earning a bachelor’s degree. Students are awarded degrees from both Duke University School of Medicine and the National University of Singapore.

Clinical neuroscience is a branch of neuroscience that focuses on the scientific study of fundamental mechanisms that underlie diseases and disorders of the brain and central nervous system. It seeks to develop new ways of conceptualizing and diagnosing such disorders and ultimately of developing novel treatments.

David Eidelberg is an American neuroscientist who is a professor of Neurology and Molecular Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He is a neuroscientist best known for applying functional imaging of the brain to study neurological diseases.

<span class="mw-page-title-main">Alim Louis Benabid</span>

Alim Louis Benabid is a French-Algerian emeritus professor, neurosurgeon and member of the French Academy of Sciences, who has had a global impact in the development of deep brain stimulation (DBS) for Parkinson's disease and other movement disorders. He became emeritus professor of biophysics at the Joseph Fourier University in Grenoble in September 2007, and chairman of the board of the Edmond J. Safra Biomedical Research Center in 2009 at Clinatec, a multidisciplinary institute he co-founded in Grenoble that applies nanotechnologies to neurosciences.

Maiken Nedergaard is a Danish neuroscientist most well known for discovering the glymphatic system. She is a jointly appointed professor in the Departments of Neuroscience and Neurology at the University of Rochester Medical Center. She holds a part-time appointment in the Department of Neurosurgery within the University of Rochester Center for Translational Neuromedicine, where she is the principal investigator of the Division of Glial Disease and Therapeutics laboratory. She is also Professor of Glial Cell Biology at the University of Copenhagen, Center for Translational Neuromedicine.

Translational neuroscience is the field of study which applies neuroscience research to translate or develop into clinical applications and novel therapies for nervous system disorders. The field encompasses areas such as deep brain stimulation, brain machine interfaces, neurorehabilitation and the development of devices for the sensory nervous system such as the use of auditory implants, retinal implants, and electronic skins.

Patrik Verstreken is a Belgian neuroscientist, highly cited in his field. His work is focused on the function of neuronal synapses during health and neurological disease. Major contributions include identifying molecular mechanisms by which neurodegenerative diseases such as Alzheimer's disease spread throughout the brain and identification of new defects causing Parkinson's disease.

Robert Y. Moore is an American neurologist with interests in disorders of biological rhythms, movement disorders, and behavioral neurology. He is credited with discovering the function of the suprachiasmatic nucleus (SCN) as the circadian clock, as well as, describing its organization. He is also credited with establishing the role of the mammalian retinohypothalamic tract (RHT) as a photic entrainment pathway. Moore cin 2017 serves as a professor of neurology, with a secondary in psychiatry and neuroscience at the University of Pittsburgh, and as co-director of the National Parkinson Foundation Center of Excellence at the University of Pittsburgh.

Ted M. Dawson is an American neurologist and neuroscientist. He is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases and Director of the Institute for Cell Engineering at Johns Hopkins University School of Medicine. He has joint appointments in the Department of Neurology, Neuroscience and Department of Pharmacology and Molecular Sciences.

Jeffrey D. Macklis is an American neuroscientist. He is the Max and Anne Wien Professor of Life Sciences in the Department of Stem Cell and Regenerative Biology and Center for Brain Science at Harvard University, Professor of Neurology [Neuroscience] at Harvard Medical School, and on the Executive Committee and a Member of the Principal Faculty of the Neuroscience / Nervous System Diseases Program at the Harvard Stem Cell Institute.

<span class="mw-page-title-main">Patrick J. Casey</span>

Patrick J. (Pat) Casey is a biochemist and molecular pharmacologist and is a James B. Duke Professor of Pharmacology and Cancer Biology at Duke University School of Medicine. In 2005, he relocated to Singapore to help found the Duke-NUS Medical School Singapore, where he continues to serve as its Senior Vice Dean of Research.

Sonia Gandhi is a British physician and neuroscientist who leads the Francis Crick Institute neurodegeneration laboratory. She holds a joint position at the UCL Queen Square Institute of Neurology. Her research investigates the molecular mechanisms that give rise to Parkinson's disease. During the COVID-19 pandemic, Gandhi was involved with the epidemiological investigations and testing efforts at the Francis Crick Institute.

<span class="mw-page-title-main">Lim Chwee Teck</span>

Chwee Teck (C.T.) Lim is a Singaporean scientist and entrepreneur. He is a specialist in human disease mechanobiology and in developing medical technologies for disease diagnosis and precision therapy and bringing them from the laboratory to the bedside.

References

  1. "Lim Kah Leong at National University of Singapore". National University of Singapore Faculty. Retrieved 2017-07-23.
  2. "Lim Kah Leong, Duke-NUS". Duke NUS Faculty. Retrieved 2017-07-23.
  3. "IMCB News". IMCB News. 2012-04-01. Retrieved 2017-07-23.
  4. Staff Reporter (2014-05-03). "First highly sensitive, small molecule fluorescence probe to evaluate risk, monitor progression of Parkinson's disease". ScienceDaily. Retrieved 2017-07-23.
  5. Boh, Samantha (2016-11-25). "Creating new nerve cells to treat Parkinson's". The Straits Times.
  6. "New insight into brain cancer". Science Alert. 2012-06-11. Retrieved 2017-07-23.
  7. "AStar Profile Page". Agency for Science Technology and Research.
  8. Staff Reporter (2014-12-29). "People and passion behind Parkinson's disease research". Tomorrow's Medicine.
  9. Loh, Victor (2018-09-25). "Top research scientists and engineers receive highest accolade". Today. Retrieved 2019-06-12.
  10. Staff (2018-09-26). "Singapore Honors Outstanding Researchers At PSTA 2018". Asian Scientist. Retrieved 2019-06-12.